UBS AM’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$780 Buy
+6
New +$681 ﹤0.01% 4151
2025
Q3
– Sell
-17,403
Closed -$1.64M – 2471
2025
Q2
$1.64M Sell
17,403
-2,574
-13% -$282K ﹤0.01% 2230
2025
Q1
$2.37M Buy
19,977
+685
+4% +$93.4K ﹤0.01% 1909
2024
Q4
$2.54M Buy
19,292
+9,189
+91% +$1.13M ﹤0.01% 1927
2024
Q3
$1.31M Buy
10,103
+1,708
+20% +$201K ﹤0.01% 2255
2024
Q2
$728K Buy
8,395
+6,080
+263% +$637K ﹤0.01% 2515
2024
Q1
$254K Hold
2,315
– – ﹤0.01% 2430
2023
Q4
$243K Hold
2,315
– – ﹤0.01% 2464
2023
Q3
$243K Sell
2,315
-1,526
-40% -$195K ﹤0.01% 2474
2023
Q2
$671K Hold
3,841
– – ﹤0.01% 2196
2023
Q1
$671K Hold
3,841
– – ﹤0.01% 2196
2022
Q4
$638K Buy
3,841
+632
+20% +$99K ﹤0.01% 2074
2022
Q3
$452K Hold
3,209
– – ﹤0.01% 2378
2022
Q2
$654K Hold
3,209
– – ﹤0.01% 2177
2022
Q1
$818K Hold
3,209
– – ﹤0.01% 2246
2021
Q4
$1.05M Hold
3,209
– – ﹤0.01% 2191
2021
Q3
$970K Hold
3,209
– – ﹤0.01% 2182
2021
Q2
$870K Sell
3,209
-1,663
-34% -$422K ﹤0.01% 2280
2021
Q1
$1.19M Hold
4,872
– – ﹤0.01% 2005
2020
Q4
$1.4M Hold
4,872
– – ﹤0.01% 1828
2020
Q3
$1.24M Buy
4,872
+205
+4% +$48.7K ﹤0.01% 1756
2020
Q2
$1.01M Buy
4,667
+1,482
+47% +$342K ﹤0.01% 1800
2020
Q1
$720K Buy
3,185
+17
+0.5% +$4.19K ﹤0.01% 1823
2019
Q4
$790K Buy
3,168
+849
+37% +$199K ﹤0.01% 2038
2019
Q3
$551K Buy
2,319
+1,226
+112% +$283K ﹤0.01% 2245
2019
Q2
$267K Buy
+1,093
New +$255K ﹤0.01% 2449

Other funds holding MLAB

UBS AM's MLAB Position: Q3 2026 in Review

UBS AM opened a new position in Mesa Laboratories (MLAB) in Q3 2026: 6 shares worth $780. The stake represents ﹤0.01% of the portfolio and ranks #4151 among its holdings. This is a return to the name: UBS AM previously reported a position in MLAB as recently as Q2 2025.

UBS AM first reported a position in MLAB in Q2 2019 and has held it in 26 quarters since. The position peaked at $2.54M in Q4 2024. 154 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • UBS AM held 6 shares of Mesa Laboratories worth $780 as of Q3 2026.
  • Mesa Laboratories was a new UBS AM position in Q3 2026.
  • Mesa Laboratories made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4151 holding.
  • UBS AM first reported a position in Mesa Laboratories in Q2 2019 and has held it in 26 quarters since.
  • UBS AM's Mesa Laboratories position peaked at $2.54M in Q4 2024.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.